The effect of transcatheter aortic valve implantation on ventricular repolarization indices and neutrophil-to-lymphocyte ratio

Aim: The electrocardiographic QT dispersion (QTd), Tpe/QT ratio and Tpeak-Tend (Tpe) interval have been known as ventricularrepolarization indices. Neutrophil–to- lymphocyte ratio (NLR) is an inflammatory marker that is newly described. Increased QTd,Tpe/QT ratio, inflammation and Tpe interval are associated with ventricular arrhythmia (VA). In patients with severe aortic stenosis(AS), VA has a key role in terms of morbidity and mortality. The present study aimed at examining whether transcatheter aortic valveimplantation (TAVI) affects ventricular repolarization indices and NLR.Material and Methods: Study population consisted of a total of 44 patients undergoing TAVI. Echocardiographic and laboratoryparameters of patients were evaluated before TAVI and sixth month after TAVI. Comparioson of electrocardiographic QTd, Tpe/QTratio, Tpe interval and NLR of the same petients were made before TAVI and sixth month after TAVI.Results: QT interval, corrected QT interval and heart rate were similar before and after TAVI (p>0.05 for all). There was a statisticallysignificant decrease in QTd (26.0±9.1 vs. 21.3±7.2 ms; p=0.008), Tpe interval (88.43±12.6vs. 78.8±10.1 ms; p

PDF

___

1. Carabello BA, Paulus WJ. Aortic stenosis. Lancet 2009; 373:956-66.
2. Kvidal P, Bergström R, Malm T. Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis. Eur Heart J 2000; 21:1099-111.
3. Levy D, Anderson KM, Plehn J, et al. Echocardiographicallydetermined left ventricular structural and functional correlatesof complex or frequent ventricular arrhythmias on onehourambulatory electrocardiographic monitoring. Am J Cardiol 1987;59:836-40.
4. Castro Hevia J, Antzelevitch C, Tornés Bárzaga F,et al. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricularfibrillation in patients with the Brugada syndrome. J Am Coll Cardiol 2006;47:1828-34.
5. Antzelevitch C, Sicouri S, Di Diego JM, et al. Does Tpeak-Tend provide an index of transmural dispersion of repolarization? Heart Rhythm 2007;4:1114-6.
6. Pereira IA, Borba EF. The role of inflammation, humoral and cell mediated autoimmunity in thepathogenesis of atherosclerosis. Swiss Med Wkly 2008;138:534-39.
7. L agrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 1999;100:96-102.
8. Mountantonakis S, Deo R. Biomarkers in atrial fibrillation, ventricular arrhythmias and sudden cardiac death. Cardiovasc Ther 2012;30:74-80.
9. Avci A, Elnur A, Göksel A,et al. The relationship between neutrophil/lymphocyte ratio andcalcific aortic stenosis. Echocardiography 2014;31:1031-5.
10. Kucukseymen S, Cagirci G, Guven, R, et al. Is neutrophyl to lymphocyte ratio really auseful marker for all grades of degenerative aortic stenosis? Turk Kardiyol Dern Ars 2017;45:506-13.
11. Makkar RR, Fontane GP, Jilaihawi H,et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenonsis. N engl J Med 2012; 366:1696-704.
12. Goldenberg I, Moss AJ, Zareba W. QT interval: how to measure it and what is “normal.” J Cardiovasc Electrophysiol 2006;17:333-6.
13. Vahanian A, Alfieri O, Andreotti F,et al. Guidelines on themanagement of valvular heart disease: The Task Force on theManagement of Valvular Heart Disease of the European Societyof Cardiology. Eur Heart J 2012; 33:2451-96.
14. Turina J, Hess O, Sepulcri F,et al. Spontaneous course ofaortic valve disease. Eur Heart J 1987;8:471-83.
15. Leon MB, Smith CR, Mack M,et al. PARTNER Trial Investigators.Transcatheter aortic-valve implantation for aorticstenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607.
16. Smith CR, Leon MB, Mack MJ,et al. PARTNER Trial Investigators.Transcatheter versus surgical aorticvalve replacementin high-risk patients. N Engl J Med 2011;364:2187-98.
17. Sorgato A, Faggiano P, Aurigemma GP,et al. Ventriculararrhythmias in adult aortic stenosis. Prevalence, mechanism,and clinical relevance. Chest 1998;113:482-91.
18. Schwartz LS, Goldfisher J, Sprague GJ,et al. Syncope andsudden death in aortic stenosis. Am J Cardiol 1969;23:647-58.
19. Klein RC. Ventricular arrhythmias in aortic valve disease: analysis of 102 patients. Am J Cardiol 1984; 53:1079-83.
20. Cowan JC, Yusoff K, Moore M,et al. Importance of leadselection in QT interval measurement. Am J Cardiol 1988;61:83-7.
21. Okin PM, Devereux RB, Howard BV,et al. Assessment ofQT interval and QT dispersion for prediction of all-cause andcardiovascular mortality in American Indians. The StrongHeart Study. Circulation 2000; 101:61-6.
22. Gupta P, Patel C, Patel H,et al. T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol 2008;41: 567-74.
23. Zhao X, Xie Z, Chu Y, et al. Association between Tp-e/ QT ratio and prognosis in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Clin Cardiol 2012;35: 559-64.
24. Tokatli A, Kilicaslan F, Alis M, et al. Prolonged TpeInterval, Tp-e/QT Ratio and Tp-e/QTc Ratio in Patients with Type 2 Diabetes Mellitus. Endocrinol Metab 2016;31:105-12.
25. Zehir R, Karabay CY, Kalayci A, et al. Evaluation of Tpe interval and Tpe/QT ratio in patients with slowcoronary flow. Anatol J Cardiol 2015;15:463-7.
26. Yayla C, Bilgin M, Akboga MK, et al. Evaluation of Tp-E Interval and Tp-E/QT ratio inpatients with aortic stenosis. Ann Noninvasive Electrocardiol 2016;21:287-93.
27. Kahraman S, Dogan A, Kalkan AK, et al. Evaluation of Tp-e interval, Tp-e/QT and Tp-e/QTc ratio in aortic valve stenosis before and after transcatheter aortic valve implantation. J Electrocardiol 2018;51:949-54.
28. Camici PG, Olivotto I, Rimoldi OE. The coronary circulationand blood flow in left ventricular hypertrophy. J Mol Cell Cardiol 2012;52:857-64.
29. Kupari M, Virtanen KS, Turto H, et al. Exclusion of coronaryartery disease by exercise thallium-201 tomography in patientswith aortic valve stenosis. Am J Cardiol 1992;70:635-40.
30. Cameron JS, Kimura S, Jackson-Burns DA, et al. ATPsensitiveK+ channels are altered in hypertrophied ventricularmyocytes. Am J Physiol 1988;255:1254-8.
31. Tamhane UU, Aneja S, Montgomery D,et al. Association Between Admission Neutrophil toLymphocyte Ratio and Outcomes in Patients With Acute Coronary Syndrome. Am J Cardiol 2008;102:653-57.
32. Cakici M, Cetin M, Dogan A, et al. Neutrophil to lymphocyte ratio predicts poor functional capacity in patients with heart failure. Turk Kardiyol Dern Ars 2014;42:612-20.
33. Kucukseymen S, Cagirci G, Guven R,et al. Is neutrophyl to lymphocyte ratio really auseful marker for all grades of degenerative aortic stenosis? Turk Kardiyol Dern Ars 2017;45:506-13.
34. Leopold JA. Cellular mechanisms of aortic valve calcification. Circ Cardiovasc Interv 2012;5:605-14.